TCW Group Inc. Trims Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

TCW Group Inc. reduced its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 288,347 shares of the medical equipment provider’s stock after selling 7,873 shares during the quarter. Intuitive Surgical accounts for about 1.3% of TCW Group Inc.’s investment portfolio, making the stock its 17th largest holding. TCW Group Inc. owned about 0.08% of Intuitive Surgical worth $150,506,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Berbice Capital Management LLC bought a new position in Intuitive Surgical during the fourth quarter worth $26,000. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical during the third quarter worth $33,000. Decker Retirement Planning Inc. bought a new position in Intuitive Surgical during the fourth quarter worth $36,000. Capital Performance Advisors LLP bought a new position in Intuitive Surgical during the third quarter worth $38,000. Finally, DT Investment Partners LLC increased its position in Intuitive Surgical by 80.0% in the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after buying an additional 36 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $591.79 on Friday. The stock’s fifty day simple moving average is $565.45 and its 200 day simple moving average is $525.06. The firm has a market cap of $210.78 billion, a price-to-earnings ratio of 92.32, a P/E/G ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. BTIG Research increased their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. UBS Group raised their price target on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday, January 27th. JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Stifel Nicolaus raised their price target on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. Finally, Royal Bank of Canada raised their price target on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 6,348 shares of company stock valued at $3,587,582 in the last 90 days. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.